Fatty acid metabolites as biomarkers for nonalcoholic fatty liver disease (NAFLD): A lipidomic and metabolomic approach

被引：0
|
作者：
Hou, S. [1 ]
Li, Z. [1 ]
Zhou, Y. H. [1 ]
Meng, T. [1 ]
Zhu, M. G. [1 ]
Yin, H. Y. [1 ]
机构：
[1] Chinese Acad Sci, Beijing, Peoples R China
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2012年 / 53卷
关键词：
non-alcoholic fatty liver disease; metabolomics; oxidative stress; free radical lipid peroxidation;
D O I：
10.1016/j.freeradbiomed.2012.08.031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
HNE.P.1
引用
收藏
页码：S244 / S245
页数：2
相关论文
共 50 条
  • [31] MALDI Imaging and High Resolution Mass Spectrometry as a Lipidomic Approach to Assess Nonalcoholic Fatty Liver Disease Pathophysiology and Biomarkers
    Le Faouder, Julie
    Butin, Noemie
    Laouirem, Samira
    Colsch, Benoit
    Paradis, Valerie
    Bedossa, Pierre
    HEPATOLOGY, 2017, 66 : 1075A - 1075A
  • [32] Lipidomics in Nonalcoholic Fatty Liver Disease: Exploring Serum Lipids as Biomarkers for Pediatric Nonalcoholic Fatty Liver Disease
    Draijer, Laura G.
    Froon-Torenstra, Denise
    van Weeghel, Michel
    Vaz, Frederic M.
    Bohte, Anneloes E.
    Holleboom, Adriaan G.
    Benninga, Marc A.
    Koot, Bart G. P.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (04): : 433 - 439
  • [33] The clinical and pathological spectrum of nonalcoholic fatty liver liver disease (NAFLD)
    Copaci, I
    Voiculescu, M
    Micu, L
    Hortopan, M
    Cojocaru, L
    JOURNAL OF HEPATOLOGY, 2002, 36 : 255 - 255
  • [34] A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD)
    Puri, P.
    Baillie, R. A.
    Wiest, M.
    Mirshahi, F.
    Sanyal, A. J.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S260 - S261
  • [35] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    Hepatology International, 2013, 7 : 755 - 764
  • [36] THE NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) CONUNDRUM: HOW TO DEFINE IT?
    Mato, J. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 5 - 5
  • [37] Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
    Kaswala, Dharmesh H.
    Lai, Michelle
    Afdhal, Nezam H.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1356 - 1364
  • [38] Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
    Xin, Xin
    Chen, Cheng
    Hu, Yi-Yang
    Feng, Qin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [39] Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging
    Koch, Lisa K.
    Yeh, Matthew M.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 37 : 83 - 90
  • [40] Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States
    Sanyal, Arun J.
    Estes, Chris
    Razavi, Homie
    HEPATOLOGY, 2016, 64 : 532A - 532A
12345